ARROW INTERNATIONAL LLC ARROW CVC/PSI KIT: 3L 7FR X 16CM/8.5FR X 10CM; CATHETER,INTRAVASCULAR,THERAPE
|
Back to Search Results |
|
Catalog Number ASK-42703-PSI1 |
Device Problem
Biocompatibility (2886)
|
Patient Problem
Anaphylactic Shock (1703)
|
Event Date 07/11/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).
|
|
Event Description
|
The complaint is reported as: "possible allergenic shock or anaphylactoid reaction, around the 5 min.Post-insertion of the cvc, pa drop to 33mmhg.Immediate shock treatment was begun.The cvc was removed as soon as possible during the surgery and changed with non-protected cvc." additional information was requested but was not available at the time of this report.
|
|
Event Description
|
The complaint is reported as: "possible allergenic shock or anaphylactoid reaction, around the 5 min.Post-insertion of the cvc, pa drop to 33mmhg.Immediate shock treatment was begun.The cvc was removed as soon as possible during the surgery and changed with non-protected cvc.".
|
|
Manufacturer Narrative
|
(b)(4).Additional information was received from the customer explaining that "pa" (from original statement "pa drop to 35mmhg") is referring to arterial pressure.The customer has also reported that "the lab testing came back as possible chlorexidine reactions".It was also reported that no cpr was required, adrenaline and steroids were administered, and the patient experienced hypotension.The patient is "fine and already back home".The device was not returned for investigation.The customer did not provide a lot number; therefore, a device history record review was performed based upon a lot number from the sales history data of the customer.No relevant findings were identified.The report of a catheter related allergic reaction was confirmed based on the customer report.The customer report confirmed that the patient had an allergy to chlorhexidine.The labeling provided with the coated catheter states "the arrowg+ard blue antimicrobial catheter is contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs." therefore, based on the reported event and customer confirmation of the patient having an allergy, unintentional use error (patient condition) likely caused or contributed to this event.Teleflex will continue to monitor and trend for reports of this nature.
|
|
Search Alerts/Recalls
|
|
|